Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


09.10.2017

3 Ann Neurol
1 J Biol Chem
6 Mov Disord
2 Neurology
1 Neuron
1 Neurosci Lett
1 Neuroscience
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. CHUANG YH, Lee PC, Vlaar T, Mulot C, et al
    Pooled analysis of the HLA-DRB1 by smoking interaction in Parkinson's disease.
    Ann Neurol. 2017 Oct 5. doi: 10.1002/ana.25065.
    PubMed     Text format     Abstract available

  2. SCHONHAUT DR, McMillan CT, Spina S, Dickerson BC, et al
    18 F-flortaucipir tau PET distinguishes established progressive supranuclear palsy from controls and Parkinson's disease: A multicenter study.
    Ann Neurol. 2017 Oct 5. doi: 10.1002/ana.25060.
    PubMed     Text format     Abstract available

  3. IRANZO A, Santamaria J, Valldeoriola F, Serradell M, et al
    Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic REM sleep behavior disorder.
    Ann Neurol. 2017 Aug 22. doi: 10.1002/ana.25026.
    PubMed     Text format     Abstract available


    J Biol Chem

  4. ASJAD HMM, Kasture A, El-Kasaby A, Sackel M, et al
    PHARMACOCHAPERONING IN A DROSOPHILA MODEL SYSTEM RESCUES HUMAN DOPAMINE TRANSPORTER VARIANTS ASSOCIATED WITH INFANTILE/JUVENILE PARKINSONISM.
    J Biol Chem. 2017 Sep 29. pii: jbc.M117.797092. doi: 10.1074/jbc.M117.797092.
    PubMed     Text format     Abstract available


    Mov Disord

  5. FORD KJ, Joop A, Memon RA, Wood KH, et al
    Pedestrian safety in patients with Parkinson's disease: A case-control study.
    Mov Disord. 2017 Oct 4. doi: 10.1002/mds.27124.
    PubMed     Text format     Abstract available

  6. WEIL RS, Pappa K, Schade RN, Schrag AE, et al
    The Cats-and-Dogs test: A tool to identify visuoperceptual deficits in Parkinson's disease.
    Mov Disord. 2017 Oct 4. doi: 10.1002/mds.27176.
    PubMed     Text format    

  7. MACLEOD AD, Dalen I, Tysnes OB, Larsen JP, et al
    Development and validation of prognostic survival models in newly diagnosed Parkinson's disease.
    Mov Disord. 2017 Oct 4. doi: 10.1002/mds.27177.
    PubMed     Text format     Abstract available

  8. SAEED U, Masellis M
    Unraveling PINK1 regulation: Ubiquitination of its mature form and insights for Parkinson's disease.
    Mov Disord. 2017 Oct 4. doi: 10.1002/mds.27171.
    PubMed     Text format    

  9. ASCHERIO A, Schwarzschild MA
    Dietary antioxidants and Parkinson's disease.
    Mov Disord. 2017 Oct 4. doi: 10.1002/mds.27194.
    PubMed     Text format    

  10. FENGLER S, Liepelt-Scarfone I, Brockmann K, Schaffer E, et al
    Cognitive changes in prodromal Parkinson's disease: A review.
    Mov Disord. 2017 Oct 5. doi: 10.1002/mds.27135.
    PubMed     Text format     Abstract available


    Neurology

  11. LEEHEY M, Luo S, Sharma S, Wills AA, et al
    Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.
    Neurology. 2017 Sep 29. pii: 10.1212/WNL.0000000000004572.
    PubMed     Text format     Abstract available

  12. HEDERA P, Davis TL
    Can lifestyle modification slow progression of Parkinson disease?
    Neurology. 2017 Sep 29. pii: 10.1212/WNL.0000000000004580.
    PubMed     Text format    


    Neuron

  13. CHU HY, McIver EL, Kovaleski RF, Atherton JF, et al
    Loss of Hyperdirect Pathway Cortico-Subthalamic Inputs Following Degeneration of Midbrain Dopamine Neurons.
    Neuron. 2017;95:1306-1318.
    PubMed     Text format     Abstract available


    Neurosci Lett

  14. KONG P, Lei P, Zhang S, Li D, et al
    Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease.
    Neurosci Lett. 2017 Sep 28. pii: S0304-3940(17)30793.
    PubMed     Text format     Abstract available


    Neuroscience

  15. LU J, Xu Y, Quan Z, Chen Z, et al
    Dysregulated MicroRNAs in Neural System: Implication in Pathogenesis and Biomarker Development in Parkinson Disease.
    Neuroscience. 2017 Sep 27. pii: S0306-4522(17)30677.
    PubMed     Text format     Abstract available


    PLoS One

  16. VAICIUKYNAS E, Verikas A, Gelzinis A, Bacauskiene M, et al
    Detecting Parkinson's disease from sustained phonation and speech signals.
    PLoS One. 2017;12:e0185613.
    PubMed     Text format     Abstract available

  17. DOUCET M, El-Turabi A, Zabel F, Hunn BHM, et al
    Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles.
    PLoS One. 2017;12:e0181844.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: